Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
높은 배당금
회사는 높은 배당금을 지급하는 회사로, 최신 배당금 지급 비율은 32.56%입니다.
공정한 가치
회사의 최신 PE은 27.04로, 최근 3년 기준 중간 백분위 범위에 속합니다.
기관 매도
최신 기관 보유 주식 수는 82.06M주이며, 전 분기 대비 4.87% 감소했습니다.
PRFDX가 보유
스타 투자자 PRFDX이(가) 이 주식 94.00주를 보유하고 있습니다.
시장 활동 감소
회사는 투자자들의 관심이 줄어들어, 최근 20일간 회전율이 -0.29입니다.